Interesting PG Put And Call Options For February 27th

Procter & Gamble (PG) is being presented as an options trade idea: selling the $132 put (bid $1.41) yields a net cost basis of $130.59 versus the $140.14 stock price, represents ~6% downside and has a 76% chance of expiring worthless, producing a 1.07% cash-return (7.80% annualized) if it does. Alternatively, selling the $150 covered call (bid $0.66) against shares bought at $140.14 offers a 7.51% total return if called by the Feb. 27 expiration, with a 77% chance of expiring worthless and a 0.47% immediate yield boost (3.44% annualized); implied volatilities are 25% (put) and 20% (call) versus a 12‑month trailing volatility of 19%.

Analysis

Market structure: The option market is signaling asymmetric demand for downside protection on PG — put IV 25% > call IV 20% while realized vol is ~19%, implying paid insurance and a skew that benefits sellers of puts. Winners are income-oriented investors and market-makers collecting elevated put premia; losers are buyers of protection and leveraged longs if a drawdown occurs. Cross-asset effects are modest but expect small bid-to-Treasuries and USD-funded demand for defensives if rates or CPI surprise, supporting staples vs cyclicals.

Risk assessment: Tail risks include a consumer-spending shock or sharp input-cost jump (raw-material/transport shock) that could send PG below the 132 strike — a low-probability but high-impact event; FX (a 5% stronger USD) would compress emerging-market revenue. Near term (days–weeks) the Feb 27 expiry is the key horizon; medium term (quarters) EPS/cost saves determine re-rating. Hidden dependencies: dividends, buyback cadence, retailer inventory cycles and upcoming CPI/earnings dates can reprice IV and assignment risk.

Trade implications: Direct tactical trades favor defined-risk income: cash-secured 132 puts (net basis $130.59) or covered calls at 150 (0.66) for a 7.5% to-expiry return; put skew suggests selling puts is better compensated than selling calls. Pair/sector: overweight PG vs underweight consumer discretionary (XLY) for 1–3 months into macro prints. Use put-spreads (132/120) to limit tail loss and size positions to 1–3% notional per trade.

Contrarian angles: Consensus underprices the value of selling short-dated puts given realized vol < implied put vol — selling defined-risk put spreads is likely underdone. Beware the behavioral trap: assignment risk during an earnings or macro shock can force unwanted long positions; historical parallels show staples rally in risk-off, so owning PG through a shallow recession has asymmetric return potential if bought at ~130–132 net basis.

Key Decisions for Investors

• Sell-to-open cash-secured PG Feb 27 2026 132 put at ~1.41 (net effective buy basis $130.59); allocate 1–3% of portfolio, close or roll if PG < $125 pre-expiry or IV spikes above 35%.
• If already long PG, sell-to-open Feb 27 2026 150 covered calls at ~0.66 to lock a 7.5% to-expiry return; plan to roll up/forward if PG > $150 or buy back if PG drops below $136 (≈3% loss) to preserve capital.
• Prefer defined-risk variants: implement a short 132 / long 120 put spread (Feb 27) instead of naked put if maximum drawdown must be capped; target net credit ≥ $0.60 and size to 1–2% portfolio risk.
• Reweight sector: increase staples overweight by +2% via PG long/covered call and reduce cyclical exposure by -2% (short XLY or reduce XLY holdings) for a 1–3 month tactical defensive tilt ahead of CPI and major earnings.